Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study-Reference-Cited by-同舟云学术

Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study

Published:2021-12 Issue: Volume:60 Page:147-154
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Gupta Sudeep^ORCID,Biswas Ghanashyam,Babu Suresh,Maksud Tanveer M.,Lakshmaiah Kuntegowdennahalli C.,Patel Jayanti G.,Raja Gopal^ORCID,Boya Rakesh R.,Patil Pramod,Choudhury Kakali,Bondarde Shailesh A.,Neve Rakesh S.,Bhat Guruprasad,Mamillapalli Gopichand,Patel Apurva A.,Patel Piyush^ORCID,Joshi Nisarg,Bajaj Vinay,Khan Mujtaba A.^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference26 articles.

1. Chemotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer: an overview;Andreopoulou;Curr Breast Cancer Rep,2013

2. Chemotherapy for metastatic breast cancer;Barni;Ann Oncol,2005

3. Drug resistance and the role of combination chemotherapy in improving patient outcomes;Yardley;Int J Breast Cancer,2013

4. Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy;Zhang;Proc Natl Acad Sci U S A,2017

5. An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study;Wang;Cancer Chemother Pharmacol,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Oral Metronomic Chemotherapy in Recurrent Refractory Advanced Gynaecological Cancer: An Experience From the Regional Cancer Centre of Eastern India;Cureus;2024-01-30